The Chief Minister's Office of Mizoram announced on Monday, 27 July 2026 that the state will receive ₹120 crore under the Government of India's FASPHI scheme for the financial year 2026–27, recognising the state's outstanding public health performance.

Context

Chief Minister Lal Duhoma shared the announcement, specifying that ₹20 crore of the allocation is earmarked for improving the Infant Mortality Rate (IMR), while the remaining ₹100 crore is designated for expanding NQAS-certified (National Quality Assurance Standards) health facilities across the state. The funds are performance-linked, meaning Mizoram has qualified for them on the basis of measurable health outcomes it has already demonstrated.

The FASPHI scheme operates as a central government incentive framework that rewards states for achieving defined public health benchmarks, channelling additional resources to those that demonstrate results rather than merely outlining plans.

Policy Backdrop

Performance-based funding for state health systems has deep roots in India's cooperative federalism architecture. The National Health Mission (NHM), launched in 2013 and building on the National Rural Health Mission (NRHM) of 2005, institutionalised the practice of tying central transfers to measurable outcomes such as IMR reduction and facility quality upgrades.

The National Quality Assurance Standards (NQAS) programme certifies public health facilities — from primary health centres to district hospitals — against a standardised quality framework. States with a higher share of NQAS-certified facilities are considered to have more resilient and accountable public health infrastructure. Northeastern states, including Mizoram, have historically received special focus under central health schemes given their geographic and demographic contexts.

Stakeholders and Impact

Mizoram's residents stand to be the most direct beneficiaries, particularly mothers and infants in districts where IMR remains a concern, and patients who depend on public health facilities. The ₹20 crore IMR-linked component is expected to fund targeted interventions — likely spanning nutrition, antenatal care, and neonatal services — while the larger ₹100 crore tranche will drive the accreditation and upgrading of more facilities to NQAS standards.

State health officials will be responsible for designing and executing the utilisation plan, and the allocation signals that Mizoram has built sufficient administrative credibility with the central government to attract performance rewards at this scale. For the broader northeastern region, the announcement reinforces the viability of the outcome-linked funding model as a path to accelerated health investment.

What's Next

The critical question going forward is how efficiently Mizoram deploys the ₹120 crore across the 2026–27 financial year and whether the investments translate into measurable improvements in IMR data and the count of NQAS-certified facilities. Central health funding of this nature typically comes with reporting obligations, and CM Lal Duhoma's government will be expected to demonstrate utilisation progress.

If Mizoram sustains its performance trajectory, the state could position itself for continued or enhanced allocations in subsequent years, reinforcing a virtuous cycle where demonstrated results attract further central investment in public health infrastructure.